SUMMARY
In mammals, the transcription factor SRY, encoded by the Y chromosome, is normally responsible for triggering the indifferent gonads to develop as testes rather than ovaries. However, testis differentiation can occur in its absence. Here we demonstrate in the mouse that a single factor, the forkhead transcriptional regulator FOXL2, is required to prevent transdifferentiation of an adult ovary to a testis. Inducible deletion of Foxl2 in adult ovarian follicles leads to immediate upregulation of testis-specific genes including the critical SRY target gene Sox9. Concordantly, reprogramming of granulosa and theca cell lineages into Sertoli-like and Leydig-like cell lineages occurs with testosterone levels comparable to those of normal XY male littermates. Our results show that maintenance of the ovarian phenotype is an active process throughout life. They might also have important medical implications for the understanding and treatment of some disorders of sexual development in children and premature menopause in women.
For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.
INTRODUCTION
Sex determination in vertebrate species exhibits a broad variety of mechanisms based either on genotype or environmental factors (Barske and Capel, 2008; Guiguen et al., 2009) . In almost all mammals the heterogametic sex is male, propagated by the inheritance of a Y chromosome. The discovery of a single gene, Sry, on the Y chromosome and its subsequent functional analysis has demonstrated that SRY is necessary and sufficient to initiate testicular development (Koopman et al., 1991; Sinclair et al., 1990) . SRY stands at the top of a genetic cascade that directs the differentiation of the bipotential gonad toward a testis fate through activation of its direct target gene Sox9 Sekido and Lovell-Badge, 2009 ). When misexpressed in XX mice or humans, SOX9, which belongs to the same family of HMG-box transcription factors as SRY but is encoded by an autosomal gene, is also able to induce testis formation (Bishop et al., 2000; Vidal et al., 2001 ). In the absence of SRY or SOX9 function the bipotential gonad develops as an ovary (Barrionuevo et al., 2006; Chaboissier et al., 2004) . Subsequent to gonadal differentiation, the different types and levels of hormones produced by the testes and ovaries dictate the differentiation of most secondary sexual characteristics (Wilhelm and Koopman, 2006) , others being dependent on the direct action of Y-and X-linked genes (Arnold, 2009) .
XX male sex reversal could result from gain of function mutations (GOF) in genes that promote testis development or loss of function mutations (LOF) in genes that oppose them or actively promote ovary development. In humans, most XX males have a functional SRY gene due to abnormal X-Y interchange during male meiosis, however some rare cases lack SRY (Pannetier et al., 2004) . Duplications affecting SOX9 can be responsible (Huang et al., 1999) , a situation that reflects experimental manipulation of mice where complete XX sex reversal can be achieved by ectopic expression in the developing XX gonad of SRY or SOX9, or of other SOX proteins that mimic these (Bishop et al., 2000; Koopman et al., 1991; Vidal et al., 2001) . XX gonads can also show testicular development in culture when treated with FGF9 or prostaglandin D2, both of which are involved in positive autoregulatory loops required to maintain high levels of SOX9 expression or activity (Kim et al., 2006; Moniot et al., 2009; Wilhelm et al., 2007) . The common denominator in all these cases of primary XX male sex reversal is the activation of SOX9 in the indifferent gonad. In the mouse, SRY has to function within a narrow time window to upregulate Sox9 otherwise the gene is repressed and ovaries develop (Hiramatsu et al., 2009) . Candidates for genes that oppose the male pathway include Nr0b1 (also called Dax1), Wnt4, Rspo1, and Foxl2. DAX1 is thought to recruit corepressors when it is complexed with steroidogenic factor 1 (SF1 or Nr5a1). The latter is a member of the nuclear receptor superfamily required for gonadal development in both sexes, but with an especially important role in testis development as it contributes to the activation of male pathway genes, including Sry and Sox9 (Sekido and LovellBadge, 2008) . Over-expression of DAX1 can lead to XY female development, however, LOF mutations have not revealed a role in ovaries (Bouma et al., 2005; Swain et al., 1998) . WNT4 and RSPO1 both serve to stabilize b-catenin, and ectopic expression of a stable form of b-catenin in XY gonads can lead to ovary development (Maatouk et al., 2008) . However, LOF mutations of Wnt4 and Rspo1 in the mouse lead to only partial XX male sex reversal, suggesting that additional factors still ensure that SOX9 activity is repressed (Chassot et al., 2008a; Jeays-Ward et al., 2003; Vainio et al., 1999) . Cases of human XX male development have been attributed to homozygous null mutations in RSPO1 (Parma et al., 2006) , or with LOF mutations in WNT4 associated with SERKAL syndrome (Mandel et al., 2008) , which might suggest that human sex determination is more sensitive than mouse to levels of b-catenin. However, care has to be taken in interpreting gonadal phenotypes after birth by which time ovotestes may have resolved into testes, or other secondary changes may have occurred. In Wnt4 mutant XX gonads, Sertoli-like cells begin to appear at late fetal stages and Leydig-like cells increase in number (Vainio et al., 1999) . This was associated with dysgenesis and loss of oocytes, and was thought to reflect other circumstances where Sertoli and Leydig-like cells appear in an XX gonad; for example in Freemartins, or when fetal ovaries are grafted to the kidney capsule, in adult XX mice carrying mutations in both estrogen receptors or in the aromatase gene (Cyp19a1), or in Sertoli/Leydig tumors in postmenopausal women (Couse et al., 1999; Guiguen et al., 2009; Sekido and Lovell-Badge, 2009 ). However, in none of these cases has it been shown whether the appearance of Sertoli-and Leydig-like cells in an ovary could be due to transdifferentiation from granulosa and theca cells as suggested by Burgoyne et al. (1988) , or differentiation from populations of immature precursor cells.
FOXL2 mutations in the human germline lead to the autosomal dominant blepharophimosis/ptosis/epicanthus inversus syndrome (BPES) associated with premature ovarian failure in females (Crisponi et al., 2001) . Furthermore, deregulated FoxL2 expression has been described in the goat polled intersex syndrome (PIS) where XX male sex reversal occurs (Pailhoux et al., 2001) . Similarly, global deletion of Foxl2 (Foxl2 À/À ) during development in mice leads to ovary dysgenesis and infertility (Schmidt et al., 2004; Uda et al., 2004) . Although the Foxl2 À/À mutant phenotype becomes apparent only late in fetal development with derepression of some testis specific genes, it could reflect the much earlier loss of Foxl2 expression, which is ovaryspecific from E12.5 (Ottolenghi et al., 2005; Schmidt et al., 2004) .
Understanding the plasticity of an adult ovary at the cellular level and the extent to which ''terminally'' differentiated gonadal cell types can switch to a new fate would provide molecular insight into not just the maintenance of the differentiated state in the mammalian gonad, but perhaps also well known postnatal sex conversion phenomena in lower vertebrates.
Here, we show that upon conditional loss of Foxl2 in the adult ovary the two major female-specific somatic cell lineages switch their cell fate revealing a rare example of true adult lineage reprogramming in vivo. While granulosa cells, which support oocytes, are reprogrammed into testis-specific Sertoli-like cells, the steroidogenic theca cell lineage upregulates 17-beta hydroxysteroid dehydrogenase type 3 (Hsd17b3), the rate-limiting enzyme in testosterone biosynthesis resulting in male-like levels of testosterone in the blood. Using a combination of genetically based oocyte-ablation experiments we demonstrate that this reprogramming is cell autonomous and oocyte-independent. We show that FOXL2 represses the testis differentiation program mainly through repression of Sox9-regulatory sequences that are required for its testis-specific expression. We extend our analysis by demonstrating that FOXL2 and estrogen receptor (ESR1) cooperate in Sox9 repression in vivo, consequently providing a mechanism by which loss of estrogen signaling can lead to gonadal sex reversal.
RESULTS

Somatic Ovary-to-Testis Transdifferentiation upon Conditional Deletion of Foxl2
To determine FOXL2 function during folliculogenesis in sexually mature female mice we created a conditional allele, flanking the single Foxl2 coding exon with loxP sites. Animals homozygous for this are referred to as Foxl2 f/f ( Figure S1 ). We also took advantage of a R26CreERT2 line that allows ubiquitous induction of Cre recombinase activity upon tamoxifen (TM) administration. This gave recombination efficiencies greater than 95% in adult ovaries when crossed to an R26lacZ reporter strain (data not shown (''conditional mutant'') mice ( Figure 1A ). Structural changes affected nearly the whole gonad, where the typical follicular structure of the ovary now resembled in appearance the seminiferous tubules of the testis. Some degenerating oocytes were still present whereas in most tubule-like structures germ cells appeared to be lost. Instead of granulosa cells, cells with all the morphological characteristics of testicular Sertoli cells were present. These displayed a prominent basal lamina, tripartite nucleoli and numerous veil-like cytoplasmatic extensions pointing toward the lumen ( Figure 1A ). Figure S3 ), directly demonstrating that deletion of Foxl2 alone is sufficient to cause postnatal sex reversal in the XX gonad.
Cell Autonomous Reprogramming of Granulosa into Sertoli-Like Cells
The short time frame of 3 weeks between TM administration and appearance of the somatic sex-reversed phenotype suggested transdifferentiation of granulosa into Sertoli-like cells, but to rule out any developmental and/or hormonal phenomena we examined when the molecular changes first occurred. Whereas 2 days after the start of TM administration FOXL2 was still detected by immunohistochemistry, a day later FOXL2 was absent from XX R26CreERT2;Foxl2 f/f but not control gonads ( Figure 2A and data not shown). In contrast SOX9 immunostaining first appeared 4 days after the start of TM administration in the former. Thus for a period of about 1 day neither FOXL2 nor SOX9 was detectable by immunohistochemistry suggesting that high expression levels of both factors are mutually exclusive. SOX9 expression started randomly within follicles where it was often first detected in mural but not in cumulus granulosa cells and thus spatially divided from the oocyte (Figure 2A ). One week after the start of TM administration SOX9 was expressed in all cells in a typical granulosa cell location, but many had already started to transdifferentiate into Sertoli-like cells despite the presence of an oocyte ( Figure 2B ). These results strongly suggest that granulosa cells undergo cell autonomous reprogramming into Sertoli-like cells upon loss of Foxl2. In contrast Table S1 ).
to granulosa cells which undergo programmed cell death (apoptosis) at the end of a follicle life cycle, major apoptosis is normally not seen in Sertoli cells. Consistent with this, the Sertoli-like cells in XX conditional mutant gonads do not undergo apoptosis and were still present after 6 months (Figures 2B and 2C) . Together these findings further support the notion that true lineage reprogramming has occurred, resulting in a stable cell type conversion.
Transdifferentiation of Granulosa Cells Is Independent of Oocyte Function
It has been proposed on the basis of indirect evidence that oocytes are required to maintain granulosa cell fate, and that in their absence the latter can transdifferentiate into Sertoli-like cells (Burgoyne et al., 1988; Guigon and Magre, 2006; McLaren, 1991) . We addressed this possibility by taking advantage of a mouse strain that expresses Cre under the control of Gdf9 regulatory sequences exclusively in oocytes of postnatal ovaries. First, we generated Gdf9Cre;Foxl2 f/f mice which were fully fertile demonstrating that FOXL2 does not play a role in oogenesis (data not shown). Next we crossed Gdf9Cre mice with a R26DTA mouse line in which Diphtheria toxin expression is activated upon Cre expression resulting in cell ablation. Gdf9Cre;R26DTA mice were viable and analysis of ovaries from 8-week old females demonstrated a complete absence of oocytes ( Figure 3A ), yet FOXL2 was still expressed and not SOX9 ( Figure 3B ). To substantiate this finding further, we compared a set of informative genes by quantitative RT-PCR in 8-week-old wild-type, Gdf9Cre;R26DTA (oocyte-depleted) and conditional mutant ovaries. Unlike the latter, the oocytedepleted ovaries showed no significant deregulation of Sox9, Foxl2, Dmrt1, HSD17b3, testatin (Cst9) or 17-beta hydroxysteroid dehydrogenase type 1 (Hsd17b1), which converts estrone into estradiol ( Figure 3C and data not shown). Finally, we ablated oocytes in 8-week old sexually mature female mice in case this had different consequences from deleting oocytes during sexual maturation. In mice, only cells that express the human Diphtheria toxin receptor (DTR) are susceptible to cell ablation upon Diphtheria toxin (DT) administration. We therefore generated Gdf9Cre;R26iDTR animals and compared their ovaries with those of control R26iDTR mice 9 days after DT administration. This is when follicles activated at the time of DT administration should have reached an antral stage (Hoage and Cameron, 1976) and by when 'granulosa' cells in XX R26CreERT2;Foxl2 f/f gonads express SOX9 after TM administration. As expected, in control R26iDTR ovaries, TUNEL assays revealed apoptosis in atretic but not preantral follicles. In contrast, both oocytes and surrounding granulosa cells underwent apoptosis in preantral follicles of Gdf9Cre;R26iDTR ovaries with no SOX9 expression detectable ( Figure 3D and data not shown). Taken together these experiments demonstrate that granulosa cells become reprogrammed into Sertoli-like cells in XX R26CreERT2;Foxl2 f/f gonads upon TM administration in a cell-autonomous way. Moreover, although consistent with oocyte health being essential for follicle growth (Eppig, 2001) , our findings challenge a long-standing hypothesis in the field that oocytes are directly required to maintain somatic cell identity during ovarian development (Guigon and Magre, 2006; McLaren, 1991) . 
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Appearance of Testosterone Producing Leydig-Like Cells upon Loss of Foxl2
It has been suggested that the supporting cell lineages of the testis and ovary arise from a common precursor during development (Albrecht and Eicher, 2001) . In contrast, the origin of the steroidogenic lineages is less clear. Adult Leydig and theca cells are both thought to be recruited from surrounding progenitor populations after birth (Haider, 2004; Skinner, 2005) . To ask whether FOXL2-positive gonadal precursor cells give rise to theca cells we generated a Cre replacement allele of the Foxl2 locus termed Foxl2 Cre ( Figure S1 ). Using this allele in combination with the R26lacZ reporter we could demonstrate that Foxl2 expressing cells indeed give rise to the theca cell lineage ( Figure S4 ). To further facilitate the analysis of FOXL2 function, we generated a mouse line (Foxl2 HAFoxl2 ) in which the endogenous Foxl2 locus is modified so that FOXL2 is N-terminally tagged with a HA-epitope. These retain full FOXL2 activity as homozygous Foxl2 HAFoxl2/HAFoxl2 female mice are fertile ( Figure S1 and data not shown). Immunohistochemical detection of HA-tagged FOXL2 protein demonstrated maintenance of FOXL2 expression in theca cells of the adult ovary ( Figure S4 ). Desert hedgehog (DHH), which has been shown to be required for specification of Leydig cells in the fetal testis (Yao et al., 2002) , is upregulated in XX Foxl2-deleted sex-reversed gonads as were many Leydig cell markers including Hsd17b3 ( Figure S2 ). Hsd17b3 was found to be expressed in sex-reversed gonads in a similar pattern to adult testis ( Figure 4A ). We therefore asked if the putative Leydig-like cells produced circulating testosterone. Indeed similar levels were found in XX gonadal sex-reversed mice and wild-type XY littermates, with a direct correlation with expression levels of Hsd17b3 (Figures 4A and 4B ). Whether loss of Foxl2 within theca cells is sufficient on its own to switch them into Leydig-like cells or rather makes them permissive for paracrine inducing molecules, such as DHH or PDGF from the Sertoli-like cells remains to be investigated Schmahl et al., 2008) . However, the differentiation of Leydig cells in aGSUCre:Foxl2 f/f XX mice, where Cre should not be active in theca cells, implies that such paracrine factors are sufficient.
Repression of TESCO by FOXL2 in the Adult Ovary
The rapid upregulation of Sox9 expression suggested direct transcriptional repression of Sox9 by FOXL2 in the ovary. Recently, the cis-regulatory element for testis-specific Sox9 expression, referred to as TESCO, has been identified (Sekido and LovellBadge, 2008) . Consistent with the activity of a TESCO-ECFP transgene during embryonic development (Sekido and LovellBadge, 2008) , ECFP was detected in Sertoli cells of the adult testis but not in granulosa cells of the adult ovary ( Figure 5A ). To ask whether TESCO is activated upon loss of Foxl2 in adult ovaries, the TESCO-ECFP reporter was crossed into the R26CreERT2;Foxl2 f/f genetic background. We observed strong TESCO activation after tamoxifen-induced Foxl2 deletion suggesting that FOXL2 may regulate TESCO in vivo ( Figure 5B ). Examination of the TESCO sequence indeed revealed predicted forkhead (FOX) binding sites ( Figure S5 wild-type ovaries and directly compared the relative enrichment obtained for specific DNA loci between the two samples. With Foxl2 HAFoxl2 ovaries we obtained a 6-fold enrichment using primers that spanned TESCO and a 7-fold enrichment around the Sox9 transcription start site compared to wild-type ovaries ( Figure 5C ), consistent with the looping model of distant regulatory elements in transcriptional initiation. In contrast, no relative enrichment was seen for other Sox9 genomic regions that served as controls. To further demonstrate that FOXL2 can negatively modulate TESCO, we performed transient transfection reporter assays employing the same DNA sequences. As shown in Figure 5D , FOXL2 attenuated activation of the TESCO-regulatory element by SF1, SOX9/SF1 or SRY/SF1 in vitro.
FOXL2 and ESR1 Cooperatively Suppress Granulosa Cell Reprogramming
A similar phenotype with appearance of Sertoli-like cells expressing Sox9 in postnatal ovaries has been described in Esr1/ Esr2 double mutant XX mice (Couse et al., 1999) . Furthermore, forkhead transcriptional regulators have been shown to be essential for estrogen receptor DNA binding in other systems such as breast cancer cell lines (Carroll et al., 2005) . Interestingly, nuclear hormone receptor DNA binding motifs are present in the TESCO sequence, raising the possibility that estrogen receptors are also binding to this Sox9 regulatory element in the adult ovary ( Figure S5) . As with FOXL2, we observed a 5-to 10-fold enrichment of ESR1-occupied sequences in ChIP assays over mock control ( Figure 6A ). Although ESR1 was not able to repress the TESCO regulatory ;Esr1 wt/f mice (data not shown) and has also not been reported in Esr1 null mutant ovaries (Couse et al., 1999 element on its own, together with FOXL2 synergistic repression was observed in transient transfection assays ( Figure 6B ). To show that the repression of the TESCO regulatory element by FOXL2 and ESR1 is mediated through the putative forkhead and estrogen receptor (ERE) binding sites within TESCO we mutated the corresponding sequences ( Figure S6 ). Mutation of all putative forkhead binding sites in TESCO did not lead to a loss of repression in transient transfection assays. This could be due to the presence of additional forkhead sites in TESCO to which FOXL2 can bind. Indeed, a recent study claims that, in addition to the 'classical' forkhead site, FOXL2 can bind a DNA binding motif that resembles two estrogen receptor DNA binding half-sites and the consensus binding site for SF1 (Benayoun et al., 2008; Carroll et al., 2005) . Consistent with this finding the combined mutation of the putative 'classical' forkhead and estrogen receptor binding sites (which may in addition be bound by FOXL2) in TESCO abolished the observed synergistic repressive effect of ESR1 together with FOXL2 in our transient transfection assay ( Figure 6B) .
Although in vitro assays are informative, DNA regulatory elements may be under additional constraints when integrated into the genome. We speculated that relief of repression of TESCO may lead to the expression of the mutated TESCO elements in the adult ovary. This would still require the presence of factors able to activate the element, and it is notable that both SF1 and SOX8, a close homolog of SOX9 are present in the adult ovary albeit at low concentrations (Salmon et al., 2005) . We therefore analyzed TESCO elements harboring different sequence mutations in transgenic animals to find that neither mutation of the forkhead sites alone nor mutation of the putative estrogen receptor binding sites alone, leads to derepression in adult ovaries. However when both types of site were simultaneously mutated, derepression of the TESCO element was observed during folliculogenesis ( Figure 6C ). Although concordant with our in vitro cotransfection results, the lack of derepression of the TESCO element upon mutation of all putative forkhead binding sites in vivo could be due to the presence of alternative sites, as discussed above, to functional redundancy between FOXL2 and ESR1 (although Foxl2 mutations are far more severe than even Esr1/2 double null mutations), or to the ability of FOXL2 and ESR1 to recruit each other via protein-protein interaction in the absence of the other's DNA binding site. We therefore tested if FOXL2 and ESR1/ESR2 can interact at the protein level. Indeed, coimmunoprecipitation experiments from HEK293 cells expressing FLAGtagged FOXL2 and V5-tagged ESR1 or ESR2 demonstrated a strong protein-protein interaction between these proteins in contrast to glucocorticoid receptor, which does not show any significant interaction with FOXL2 under the same conditions ( Figure 6D ). Finally, we tested the observed interaction of Figure 6E and data not shown).
DISCUSSION
Although sex determination is essential for successful reproduction of most species within the animal kingdom the underlying molecular mechanisms are marginally conserved from Drosophila to man. At least vertebrates have a common set of transcriptional regulators known to be involved, including DAX1, DMRT1, SF1, SOX9, FOXL2 and WT1, as well as some signaling molecules such as FGF9 and WNT4 (Barske and Capel, 2008; Guiguen et al., 2009; Shoemaker and Crews, 2009 ). However, their molecular interplay and epistatic relationships seem highly variable and are still far from being understood.
In mammals, SRY is the dominant switch initiating testes development, and it does so by directly upregulating the expression of Sox9 in cells of the supporting cell lineage (Sekido and Lovell-Badge, 2008) . Once above a critical threshold, SOX9 initiates several positive autoregulatory loops that maintain the high levels of SOX9 expression and activity that are necessary for Sertoli cell differentiation and function. These ''feedforward'' mechanisms, which make continued expression of SRY unnecessary, include SOX9 binding together with SF1 to its own regulatory region, as well as the upregulation of Fgf9 and prostaglandin D synthase (Ptgds), each of which make extracellular signaling molecules that act back on early Sertoli cells (Kim et al., 2006; Wilhelm et al., 2007) . The maintenance of high levels of SOX9 and subsequent Sertoli cell differentiation and testis development can be overridden by manipulating WNT pathway activation through overexpression of a stable form of b-catenin in XY gonads (Maatouk et al., 2008) . This finding has its conceptual counterpart in the XX gonad where loss of either the WNT pathway activator R-Spondin or Wnt4 can lead to Sox9 upregulation and XX male sex reversal, albeit with weak or partial phenotypes (Chassot et al., 2008b; Tomizuka et al., 2008; Vainio et al., 1999) . Misexpression of Sox9 itself can give robust XX male sex reversal (Bishop et al., 2000; Vidal et al., 2001 ). However, these examples of sex reversal, together with numerous others in different mammalian species, occur as a result of an altered cell fate decision of the common supporting cell lineage precursor during development. They do not address the question whether 'terminally' differentiated Sertoli or granulosa cells can switch or flip-flop from one fate to that of the other as suggested by Burgoyne et al. (1988) . The demonstration here that upon loss of Foxl2 mature granulosa/theca cells undergo transdifferentiation into Sertoli/Leydig-like cells with high levels of testosterone production is one of the few documented examples of in vivo lineage reprogramming in an adult organism (Zhou and Melton, 2008) .
FOXL2 and SOX9: Yin and Yang of Sex Maintenance
Like Yin and Yang, FOXL2 and SOX9 oppose each other's action to ensure together the establishment and maintenance of the different female and male supporting cell types respectively (Figure 7) . The observed upregulation of Sox9 as well as its testis-specific regulatory element TESCO upon loss of FOXL2 function in mature granulosa cells not only demonstrates that FOXL2 represses Sox9 expression but also begs the question as to the identity of the positive factors required for Sox9 upregulation in the absence of SRY? These could include extrinsic factors known to be involved in positive feedback loops in the early testis, such as FGF9, PGD2 or related family members, which by themselves are each capable of stimulating high levels of SOX9 in the early embryonic gonad in culture, or it could involve intrinsic factors able to mimic SOX9 (Sekido and Lovell-Badge, 2009 ). As Sox9 and Foxl2 are also expressed in a mutually exclusive way in the gonads of many lower vertebrate species, the suggested trans-repression between the two factors seems to be an evolutionary conserved mechanism (Barrionuevo et al., 2006; Chaboissier et al., 2004; Uhlenhaut and Treier, 2006) . It is therefore tempting to speculate that this mechanism is central to the maintenance of the gonadal sexual phenotype in vertebrates and supports the model in which the decisive issue that determines the outcome of mammalian sex development and maintenance is whether SOX9 can establish an auto-regulatory self-maintaining loop or not (Kim et al., 2006; Sekido and Lovell-Badge, 2008) . Although Foxl2 is upregulated in Sox9-conditional null mutant XY gonads (Barrionuevo et al., 2006) , direct repression of Foxl2 expression by SOX9 remains to be demonstrated.
As shown here, the maintenance of female gonadal sex requires continuous expression of FOXL2 to suppress male development. Due to the infertility of human females heterozygous for FOXL2 mutations, the homozygous loss-of-function phenotype has not yet been reported. In the mouse global Foxl2 deletion, such as a null deletion (Foxl2 À/À ) or replacement with lacZ (Foxl2 lacZ/lacZ ) leads to ovary dysgenesis but not to sex reversal (gonadal or otherwise) during development in contrast to the deletion at adult stages reported here (Schmidt et al., 2004; Uda et al., 2004) . Due to the observed upregulation of SOX9 during perinatal stages in Foxl2 À/À ovaries, it was suggested that granulosa cells have transdifferentiated into Sertoli-like cells (Ottolenghi et al., 2005) . However, our comparison of genome wide gene expression profiles revealed that postnatal Foxl2 null mutant XX gonads do not show upregulation of most of the 200 testis-specific genes observed in the conditional mutant, such as Rhox8, Sox8, Ncoa2/TIF2, Tsx and Insl3, suggesting that despite expression of SOX9 they have not transdifferentated into bonafide Sertoli-like cells (Figures S7 and S8) . Importantly, we find that R-Spondin1 (Rspo1), which is still robustly expressed in P3 wild-type ovaries, is more than 2-fold upregulated in Foxl2 null mutant ovaries (Chassot et al., 2008a) . In contrast, Rspo1 is no longer significantly expressed in adult ovaries nor is it upregulated in the conditional mutant ( Figure S8 ).
The WNT Pathway and FOXL2 Act Independently during Gonadal Development Mutations in R-Spondin1 lead to female-to-male sex reversal in at least some humans and partially in mice, as does the global disruption of murine Wnt4. This has led to the realization that the WNT/b-catenin pathway is important for development of the female gonad (Chassot et al., 2008b; Maatouk et al., 2008; Parma et al., 2006; Tomizuka et al., 2008; Vainio et al., 1999) . In all these cases Foxl2 is still expressed, suggesting that Foxl2 is not regulated by WNT signaling and acts independently to regulate SOX9 activity. We speculate that defined temporal developmental windows of Rspo1 expression are essential to allow the mutually exclusive expression of Sox9 and Foxl2 and its deregulation may explain in part the variable outcome of Foxl2 deletion seen in different species (Figure 7 ). This also argues the independence of the two ''anti-testis'' pathways represented by FOXL2 and R-Spondin1/b-catenin and that (as a minimum) both need to be lost to allow robust differentiation of testicular cell types. In contrast to a previous report we do not find a synergistic interaction between Wnt4 and Foxl2 (Ottolenghi et al., 2007) (Figure S9 ), and in accordance with the observed upregulation of Rspo1 in Foxl2 null mutants these data further suggest that negative regulation of SOX9 activity through the WNT pathway is epistatic and dominant over FOXL2 activity during XX gonadal development at least until birth.
The Steroid Connection: Interaction of FOXL2 and ESR1
In contrast to eutherian mammals, other vertebrate species, even those employing genetic based sex determination mechanisms, are sensitive to the application of exogenous hormones (Barske and Capel, 2008; Guiguen et al., 2009; Shoemaker and Crews, 2009 ). In particular estrogens have long been known to be important for ovarian differentiation and they are able to trigger male to female sex reversal in fish, reptiles and birds, whereas decreasing estrogen levels in these species has the opposing effect resulting in phenotypic males from females (Guiguen et al., 2009; Nakamura, 2009) . Exogenous estrogens can even trigger XY ovary development in marsupials (Coveney et al., 2001 phenomena are far from being understood. The demonstration that FOXL2 and estrogen receptor interact in controlling granulosa cell identity at least in part through repression of Sox9 expression suggest that similar mechanisms operate in lower vertebrate species, as Foxl2 is one of the few conserved ovarian differentiation genes (Uhlenhaut and Treier, 2006) . Furthermore it validates in vivo the proposed importance of forkhead factors for estrogen receptor function (Carroll et al., 2005) . While this early dependence on estrogens for ovary differentiation is not evident in most eutherian mammals, this may not be true of all. In contrast to the mouse, where there is no ovarian steroidogenesis during fetal development, ruminants such as the goat show precocious production of estrogens from the earliest stages of ovary development. This is evident from the onset of expression of CYP19a1. Pannetier et al. (2006) have shown that Cyp19a1 is regulated by FOXL2 in the fetal goat ovary, as we show here for adult mice ( Figure 1B) . Therefore, in animals with PIS, estrogens will be absent in addition to FOXL2 from early stages. As the PIS phenotype is evident much earlier than in Foxl2 null mutant XX mice, this suggests that estrogen activity may have replaced the RSPO1/ WNT/b-catenin pathway as the predominant anti-testis or ovary differentiation mechanism during fetal development in goats. Our results therefore strongly suggest that FOXL2 deficiency is the sole underlying cause of female-to-male sex reversal seen in the goat polled intersex syndrome (Pailhoux et al., 2001) .
ESR1/2 null mutant mice show a phenotype similar to that of the Foxl2 conditional mutation, with post-pubertal appearance of Sertoli-like cells and testis-tubule like structures in ovaries (Couse et al., 1999) . The origin of the Sertoli-like cells was not resolved, indeed it was attributed to the loss of oocytes, which we show here is more likely to be a consequence of Sertoli cell differentiation than a cause. Thus our demonstration that 'terminally' differentiated somatic ovarian cell types can cell autonomously switch their fate not only extends our understanding of how mammalian sex is maintained but also reveals the presence in mammals of an evolutionary conserved mechanism of vertebrate sex determination.
FOXL2, SOX9, DMRT1, DAX1, and CYP19a1: Who Depends on Whom? Although we have demonstrated that FOXL2 regulates Sox9 expression, many of the other suggested interactions within the proposed transcriptional network underlying sex determination/maintenance are mainly based on temporal gene expression patterns and have not been rigorously tested. DMRT1 is required for postnatal testis differentiation in mice and its homologs have been shown or suggested to be master sex-determining genes in the chicken and in some medaka species (Guiguen et al., 2009; Raymond et al., 2000; Smith et al., 2009) . The observation that one of the strongest upregulated genes in the ovary upon Foxl2 deletion is Dmrt1, and that FOXL2 and DMRT1 appear to exhibit opposing effects on the regulation of estrogen production in fish, suggests that FOXL2 (together with estrogen receptor) may directly repress Dmrt1 transcription. Similarly, upregulation of Dax1, an established negative regulator of SF1, upon conditional Foxl2 deletion in the ovary may be due to derepression mechanisms. Alternatively, activation of these two genes may result from upregulation of SOX9. The temporal appearance of SOX9 and DMRT1 in granulosa cells upon Foxl2 deletion supports the latter suggestion ( Figure S10) . A similar unresolved matter is the transcriptional regulation of Cyp19a1, the strongest downregulated gene upon conditional Foxl2 deletion, in which FOXL2 and DMRT1 have been implicated ( Figure 1B) (Guiguen et al., 2009) . The establishment of the inducible system of somatic ovarian reprogramming presented here will now allow the definite clarification of the transcriptional interaction network underlying the maintenance of mammalian gonadal sex.
In conclusion, we show that the mammalian ovarian phenotype has to be maintained throughout adulthood, mainly by active repression of the Sertoli cell-promoting gene Sox9, and that FOXL2 (acting together with estrogen receptors) is the critical factor responsible for this. The realization that granulosa/theca cells in the adult ovary retain the plasticity to transdifferentiate into long-lived Sertoli/Leydig cells with subsequent testosterone production also has important implications for reproductive biology, in particular the treatment of sex differentiation disorders in children, as well as premature ovarian failure and female menopause, both of which are associated with declining estrogen levels and occasional signs of masculinization.
EXPERIMENTAL PROCEDURES
Mouse Strains
All mouse strains used are described in Supplemental Experimental Procedures.
Histochemistry
In situ hybrydisation was perfodrmed on 20 mm cryosections as described in Supplemental Experimental Procedures. For immunohistochemistry, 20 mm cryosections of 2% paraformaldehyde fixed ovaries were used (Leica 3050S). Sections were incubated in blocking solution (PBS containing 0.4% Triton-X, 5%) for 1 hr at room temperature followed by overnight incubation with the primary antibodies at 4 C. The sections were washed (0.4% Triton-X in PBS) and incubated for 1 hr at room temperature with the secondary antibodies. FOXL2 was detected with a rabbit antibody described in Schmidt et al. (2004) diluted 1:100. SOX9 was detected using an antibody described in Stolt et al. (2003) diluted 1:200. ECFP was detected using an a-GFP antibody (Torrey Pines Biolabs) diluted 1:500. DMRT1 was detected using an antibody described in Raymond et al. (2000) diluted 1:2000.
Serum Testosterone Measurements
Venous blood was collected from the orbital sinus of mice. Serum was frozen at À20 C until assayed. Serum testosterone levels were measured by RIA in collaboration with Dr. A. F. Parlow at the National Hormone and Peptide Program, HUMC.
Protein Coimmunoprecipitation HEK293 cells were transfected with expression vectors for murine Flag-tagged FOXL2 and V5-tagged ESR1, ESR2, or Glucocorticoid Receptor (GR) cDNAs using Fugene (Roche). After 48 hr, Co-IPs were performed by incubating cleared cell lysates in the presence of Flag M2 beads (Sigma) overnight at 4 C, followed by washing and standard Western blotting using either anti-V5-HRP or anti-Flag-HRP antibodies. The nuclear receptor cDNAs were a generous gift from J. Jonker (Salk Institute).
Diphtheria Toxin Oocyte Ablation Experiment
Diphtheria toxin (DT) (List Biological Laboratories, Campbell, CA) was dissolved in PBS and 8-week old female mice were injected three times i.m with a 48 hr gap between each injection (50 mg/kg). Mice were killed and ovaries dissected for analysis 9 days after the first injection.
Statistical Analysis
Values are given as the means ± SEM. Data were analyzed by Student's t test. Statistically significant threshold was accepted as p < 0.05.
ACCESSION NUMBERS
The genome-wide profiling data discussed in this publication have been deposited in the NCBI GEO repository, accession number GSE16853.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supplemental References, two tables, ten figures, and a video summary and can be found with this article online at http://www.cell.com/supplemental/ S0092-8674(09)01433-0.
